Skip to main content

Table 6 Recurrence and survival

From: Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis—a cohort study of 123 patients from a non-endemic country

 

SRCC (n = 34)

Non-SRCC (n = 33)

p

Tumor recurrence

8 (32%)

10 (35.7%)

0.776

Liver metastases

1 (2.9%)

6 (60%)

0.096

Peritoneal carcinosis

5 (62.5%)

2 (6%)

 

Loco-regional

2 (5.8%)

2 (6%)

 

5-year survival

16 (47.1%)

17 (51.5%)

0.715

Superficial cancer

3 (100%)

4 (80%)

0.408

Invasive cancer

13 (41.9%)

13 (48.1%)

0.635